Jimmy Kerrigan currently works at the Department of Cardiovascular Diseases at the Cleveland Clinic as an Interventional Cardiology Fellow, finishing his training in 2019. Jimmy does research in Interventional Cardiology. His most recent publication is "Anticoagulation Management Issues in Pericarditis-induced Atrial Fibrillation." He is interested in sexual and racial disparities in transcatheter aortic valve replacement (TAVR) and in outcomes of various types of anesthesia in structural interventional procedures.